Peijia Medical Ltd. engages in the manufacture and sale of medical devices. The company is headquartered in Suzhou, Jiangsu and currently employs 1,035 full-time employees. The company went IPO on 2020-05-15. The firm primarily operates its businesses through two segments, Transcatheter Valve Therapeutic Business segment and Neurointerventional Business segment. Transcatheter Valve Therapeutic Business segment is mainly engaged in the business of research and development, manufacturing and sales of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is mainly involved in the business of research and development, manufacturing and sales of neurointerventional procedural medical devices. The Company’s products include commercialized products such as TaurusOne and TaurusElite. The firm mainly conducts its businesses in the domestic market.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenue
667
615
441
250
136
38
Revenue Growth (YoY)
28.99%
39%
76%
84%
258%
111%
Cost of Revenue
205
181
115
74
40
13
Gross Profit
462
433
325
176
95
25
Selling, General & Admin
473
456
453
354
196
126
Research & Development
218
192
284
366
440
98
Operating Expenses
670
663
741
725
646
233
Other Non Operating Income (Expenses)
--
--
0
--
--
--
Pretax Income
-222
-221
-391
-398
-574
-2,068
Income Tax Expense
6
6
1
9
0
0
Net Income
-225
-226
-392
-407
-574
-2,068
Net Income Growth
-10%
-42%
-4%
-28.99%
-72%
289%
Shares Outstanding (Diluted)
665.99
669.48
679.27
673.16
661.65
466.99
Shares Change (YoY)
-2%
-1%
1%
2%
42%
2%
EPS (Diluted)
-0.34
-0.33
-0.57
-0.6
-0.86
-4.42
EPS Growth
-8%
-41%
-5%
-30%
-80%
281%
Free Cash Flow
-368
-285
-899
-578
-637
-209
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
69.26%
70.4%
73.69%
70.39%
69.85%
65.78%
Operating Margin
-31.18%
-37.23%
-94.33%
-219.2%
-405.14%
-544.73%
Profit Margin
-33.73%
-36.74%
-88.88%
-162.79%
-422.05%
-5,442.1%
Free Cash Flow Margin
-55.17%
-46.34%
-203.85%
-231.2%
-468.38%
-550%
EBITDA
-174
-170
-374
-512
-524
-188
EBITDA Margin
-26.08%
-27.64%
-84.8%
-204.8%
-385.29%
-494.73%
D&A For EBITDA
34
59
42
36
27
19
EBIT
-208
-229
-416
-548
-551
-207
EBIT Margin
-31.18%
-37.23%
-94.33%
-219.2%
-405.14%
-544.73%
Effective Tax Rate
-2.7%
-2.71%
-0.25%
-2.26%
0%
0%
Follow-Up Questions
What are Peijia Medical Ltd's key financial statements?
According to the latest financial statement (Form-10K), Peijia Medical Ltd has a total asset of $0, Net loss of $-226
What are the key financial ratios for PEJMF?
Peijia Medical Ltd's Current ratio is 0, has a Net margin is -36.74, sales per share of $0.91.
How is Peijia Medical Ltd's revenue broken down by segment or geography?
Peijia Medical Ltd largest revenue segment is Neurointerventional, at a revenue of 385,492,551 in the most earnings release.For geography, China is the primary market for Peijia Medical Ltd, at a revenue of 667,321,372.
Is Peijia Medical Ltd profitable?
no, according to the latest financial statements, Peijia Medical Ltd has a net loss of $-226
Does Peijia Medical Ltd have any liabilities?
no, Peijia Medical Ltd has liability of 0
How many outstanding shares for Peijia Medical Ltd?
Peijia Medical Ltd has a total outstanding shares of 0